Evaluation of Different Breast Cancer Screening Strategies for High-Risk Women in Beijing, China: A Real-World Population-Based Study

Background Mammography-based breast cancer screening has been widely implemented in many developed countries. Evidence was needed on participation and diagnostic performance of population-based breast cancer screening using ultrasound in China. Methods We used data from the Cancer Screening Program in Urban China in Beijing from 2014 to 2019 and was followed up until July 2020 by matching with the Beijing Cancer Registry database. Eligible women between the ages of 45 and 69 years were recruited from six districts and assessed their risk of breast cancer through an established risk scoring system. Women evaluated to be at high risk of breast cancer were invited to undergo both ultrasound and mammography. Participation rates were calculated, and their associated factors were explored. In addition, the performance of five different breast cancer screening modalities was evaluated in this study. Results A total of 49,161 eligible women were recruited in this study. Among them, 15,550 women were assessed as high risk for breast cancer, and 7,500 women underwent ultrasound and/or mammography as recommended, with a participation rate of 48.2%. The sensitivity of mammography alone, ultrasound alone, combined of ultrasound and mammography, ultrasound for primary screening followed by mammography for triage, and mammography for preliminary screening followed by ultrasound for triage were19.2%, 38.5%, 50.0%, 46.2%, and 19.2%, and the specificity were 96.1%, 98.6%, 94.7%, 97.6%, 95.7%, respectively. The sensitivity of combined ultrasound and mammography, ultrasound for primary screening followed by mammography for triage, was significantly higher than mammography alone (p=0.008 and p=0.039). Additionally, ultrasound alone (48,323 RMB ($7,550)) and ultrasound for primary screening followed by mammography for triage (55,927 RMB ($8,739)) were the most cost-effective methods for breast cancer screening than other modalities. Conclusions Ultrasound alone and ultrasound for primary screening and mammography are superior to mammography for breast cancer screening in high-risk Chinese women.

[1]  Dennis Andersson,et al.  Ensuring trust in COVID-19 data , 2021, Medicine.

[2]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[3]  Xi Lin,et al.  The diagnostic performance of automated versus handheld breast ultrasound and mammography in symptomatic outpatient women: a multicenter, cross-sectional study in China , 2020, European Radiology.

[4]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[5]  Rachel Shikhman,et al.  Breast Imaging Reporting and Data System , 2020, Definitions.

[6]  A. Quante,et al.  Is risk-stratified breast cancer screening economically efficient in Germany? , 2019, PloS one.

[7]  D. Hughes,et al.  Digital Breast Tomosynthesis Implementation: Considerations for Emerging Breast Cancer Screening Bundled Payment Models. , 2019, Journal of the American College of Radiology : JACR.

[8]  Riccardo Manfredi,et al.  Automated Breast Ultrasonography (ABUS) in the Screening and Diagnostic Setting: Indications and Practical Use. , 2018, Academic radiology.

[9]  J. Seely,et al.  Screening for breast cancer in 2018-what should we be doing today? , 2018, Current oncology.

[10]  Ning Wang,et al.  Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. , 2018, The Lancet. Global health.

[11]  J. Sitt,et al.  Understanding breast cancer screening--past, present, and future. , 2018, Hong Kong medical journal = Xianggang yi xue za zhi.

[12]  Melissa Matz,et al.  Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries , 2018, The Lancet.

[13]  J. Ji,et al.  Cancer incidence in Beijing, 2014. , 2018, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[14]  A. Vourtsis,et al.  The performance of 3D ABUS versus HHUS in the visualisation and BI-RADS characterisation of breast lesions in a large cohort of 1,886 women , 2018, European Radiology.

[15]  Sung Hun Kim,et al.  Application of computer-aided diagnosis in breast ultrasound interpretation: improvements in diagnostic performance according to reader experience , 2017, Ultrasonography.

[16]  T. Poulton,et al.  Digital Breast Tomosynthesis: Cost-Effectiveness of Using Private and Medicare Insurance in Community-Based Health Care Facilities. , 2017, AJR. American journal of roentgenology.

[17]  Nico Karssemeijer,et al.  Volumetric breast density affects performance of digital screening mammography , 2016, Breast Cancer Research and Treatment.

[18]  F. Song,et al.  Preliminary effectiveness of breast cancer screening among 1.22 million Chinese females and different cancer patterns between urban and rural women , 2016, Scientific Reports.

[19]  Anand K. Narayan,et al.  Comparative effectiveness of breast MRI and mammography in screening young women with elevated risk of developing breast cancer: a retrospective cohort study , 2016, Breast Cancer Research and Treatment.

[20]  T. Endo,et al.  Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial , 2016, The Lancet.

[21]  K. Straif,et al.  Breast-cancer screening--viewpoint of the IARC Working Group. , 2015, The New England journal of medicine.

[22]  Bin Zhang,et al.  A multi-centre randomised trial comparing ultrasound vs mammography for screening breast cancer in high-risk Chinese women , 2015, British Journal of Cancer.

[23]  N. Boyd,et al.  Mammographic features associated with interval breast cancers in screening programs , 2014, Breast Cancer Research.

[24]  Yaogang Wang,et al.  Distribution of mammographic density and its influential factors among Chinese women. , 2014, International journal of epidemiology.

[25]  Wanqing Chen,et al.  Breast cancer in China. , 2014, The Lancet. Oncology.

[26]  Yi Wang,et al.  Comparative study of automated breast 3-D ultrasound and handheld B-mode ultrasound for differentiation of benign and malignant breast masses. , 2013, Ultrasound in medicine & biology.

[27]  C. de Wolf,et al.  Mammographic Screening Programmes in Europe: Organization, Coverage and Participation , 2012, Journal of medical screening.

[28]  Y. Qiao,et al.  A Nation-Wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in china , 2011, BMC Cancer.

[29]  A. Derossis,et al.  Is Breast Cancer the Same Disease in Asian and Western Countries? , 2010, World Journal of Surgery.

[30]  S. Haneuse,et al.  Performance of first mammography examination in women younger than 40 years. , 2010, Journal of the National Cancer Institute.

[31]  J. Lakshmanan,et al.  Randomised controlled trial , 2006 .

[32]  MD EttaD.Pisano,et al.  Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. , 2008, Radiology.

[33]  D. Miglioretti,et al.  Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. , 2007, Journal of the National Cancer Institute.

[34]  Emily White,et al.  Factors contributing to mammography failure in women aged 40-49 years. , 2004, Journal of the National Cancer Institute.

[35]  T. M. Kolb,et al.  Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. , 2002, Radiology.

[36]  W. Willett,et al.  Harvard Report on Cancer Prevention Volume 4: Harvard Cancer Risk Index , 2004, Cancer Causes & Control.